On January 20th, 2017, almost exactly eleven years to the day since I was thrown into this work in the food allergy world, I heard from from Mylan’s communication’s department for the first time. They wanted to discuss points made in a recent FOX interview. I was grateful. After a decade of working in this space,…
Mylan, the company that markets the EpiPen, is about to become much more well known in ways their CEO never imagined.
A funny thing happened on the way to the email box. A PR reached out to me from Mylan Pharmaceuticals
KALÉO announced today that AUVI-Q will be available by prescription nationwide on February 14, 2017. This is a story we have been following since twin brothers, Eric and Evan Edwards, first launched the device several years ago.
The head of CVS Pharmacy, the mother of a child with a life threatening food allergy, helped bring about an alternative to Mylan’s over priced EpiPen.
Today, a family in Florida gathers to honor their 11 year old son, Oakley. Friends are gathering there and around the world for the beautiful boy who loved wearing red sneakers and lost his life to a food allergic reaction.
kaléo, the inventors of AUVI-Q, have committed to making the innovative epinephrine auto-injector in the first half of 2017 as an alternative for the life-threatening allergy community.
British Society for Allergy and Clinical Immunology (BSACI) has issued nonsensical recommendations that people at risk of anaphylaxis from food allergies only carry one epinephrine autoinjector.
We all may be sick of hearing of the wrongdoings of Mylan with their EpiPen price gouging. But the situation is actually worse than the media has reported.
A father from West Virginia eloquently voices his disgust with Heather Bresch and Mylan for their EpiPen price gouging practices.